Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 


Immunity drives cancer into permanent growth arrest

Martin Röcken and his team at the Department of Dermatology, Eberhard Karls University Tuebingen, found that anti-cancer immunity is capable of driving cancers and single cancer cells into a permanent growth arrest (1).

Scientifically this permanent growth arrest is called senescence (2, 3). As complete cancer eradication is normally not feasible, deadly metastases normally result from surviving and regrowing cancer cells. The new data now explain, how immunity and immunotherapies can efficiently control surviving cancer cells and thus protect from cancer and metastases (1, 4).

Fig. 1: In red, the expression of a senescence marker in former proliferating melanoma cells that underwent growth arrest. Here, senescence occurred in the context of melanoma regression induced by a natural anti-melanoma immune response. In brown, pigment bearing cells.
University Hospital Tübingen

„The major goal of cancer therapy is the eradication, if possible of all cancer cells. Yet, we have learned over the past 50 years that some cancer cells survive even the most aggressive, cancer cell-killing therapy. It is assumed that such surviving cancer cell restore the cancer and cause the deadly metastases. This casts doubt on a therapeutic strategies that focus exclusively on cancer cell killing. Therefore, it was repeatedly postulated that, in addition to cancer cell killing, other (immune-) mechanisms are needed to control cancer (5, 6, 7).“ – as summarized by Professor Röcken.

The Tuebingen research team uncovered a critical, so far unknown immune mechanism that allows to permanently paralyze growing cancer cells. They showed for the first time that immune responses can cause a permanent growth arrest in cancers and also in single cancer cells (1). Scientifically this permanent growth arrest is termed senescence (2, 3).

Even under conditions where the immune system cannot kill the cancer, the two cytokines interferon (IFN) and tumor necrosis factor (TNF), may drive cancers into senescence. Thus, senescence induction causes a state, where ‚the cancer sleeps well controlled in his host’. This was first shown in an islet cancer of the pancreas (1, 4).

The same two cytokines, IFN and TNF, can drive a large number of mouse and human cancer cells into senescence. Clinically, this has two major consequences: Immune-induced senescence (figure 1) is obviously a physiological mechanism that contributes to the natural cancer control in humans (1). On the other side, recent data from cancer immune therapy suggest that the therapy is primarily efficient under conditions where the immune therapy causes permanent growth arrest of the metastases (8, 9).

Two mediators that are long known in cancer and infection immunology turn into the focus: interferon (IFN) and tumor necrosis factor (TNF). Many clinicians and researchers tried to destroy cancer and cancer-supplying vessels – like the Tuebingen researchers. Surprisingly, the Tuebingen group found that a certain combination of IFN and TNF protects mice from the development of islet cancers in the pancreas.

In the animals induction of senescence resulted in unexpectedly long protection from cancer (4). Even more important: when isolated from cancer prone animals, the ‘senescent cancer cells’ remained growth arrested without any further therapy, even when transferred into immune deficient, healthy mice. Thus, the senescent cancer cells had lost the aggressive behavior that characterizes cancer and remained well controlled (1).

This new therapeutic strategy offers the opportunity to develop new cancer immunotherapy that should be less aggressive, with relatively few side effects but highly efficient. Professor Rocken: „It is likely that in the future we will not primarily try to destroy cancer with ever more toxic regimen; instead we will focus on strategies that restore the body’s immune control over cancers “.

Media contact

Eberhard Karls University Tuebingen
Department of Dermatology
Prof. Dr. Martin Röcken
Liebermeisterstr. 25, 72076 Tuebingen
Tel. +49 (0)7071 29 84574
Fax +49 (0)7071/29 5450
1. Braumüller, H, Thomas Wieder, T, Brenner, E, Aßmann, S, Hahn, M, Alkhaled, M, Schilbach, K, Essmann, F, Kneilling, M, Griessinger, C, Ranta, F, Ullrich, S, Mocikat, R, Braungart, K, Mehra, T, Fehrenbacher, B, BerdeL, J, Meier, F, van den Broek, M, Häring, HU, Handgretinger, R, Quintanilla-Martinez, L, Fend, F, Pesic, M, Bauer, J, Zender, L, Schaller, M, Schulze-Osthoff, K, Röcken, M. T-helper-1-cell cytokines drive cancer into senescence.

Nature (online 04.02.2013). doi:10.1038/nature11824.

2. Michaloglou, C. et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436, 720-724 (2005).
3. Braig, M. et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436, 660-665 (2005).
4. Müller-Hermelink, N. et al. TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis. Cancer Cell 13, 507-518 (2008).
5. Sporn, MB. The war on cancer. The Lancet 347, 1377-1381 (1996).
6. Gatenby, RA. A change of strategy in the war on cancer. Nature 459, 508-509 (2009).

7. Röcken, M. Early tumor dissemination, but late metastasis: insights into tumor dormancy. J. Clin. Invest. 120, 1800-1803 (2010).

8. Walter S, et al. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat. Med. 18, 1254–1261 (2012).

9. Brahmer JR, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med. 366; 2455-2465 (2012).

Dr. Ellen Katz | idw
Further information:

More articles from Health and Medicine:

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

nachricht Flexible sensors can detect movement in GI tract
11.10.2017 | Massachusetts Institute of Technology

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Topologische Isolatoren: Neuer Phasenübergang entdeckt

Physiker des HZB haben an BESSY II Materialien untersucht, die zu den topologischen Isolatoren gehören. Dabei entdeckten sie einen neuen Phasenübergang zwischen zwei unterschiedlichen topologischen Phasen. Eine dieser Phasen ist ferroelektrisch: das bedeutet, dass sich im Material spontan eine elektrische Polarisation ausbildet, die sich durch ein äußeres elektrisches Feld umschalten lässt. Dieses Ergebnis könnte neue Anwendungen wie das Schalten zwischen unterschiedlichen Leitfähigkeiten ermöglichen.

Topologische Isolatoren zeichnen sich dadurch aus, dass sie an ihren Oberflächen Strom sehr gut leiten, während sie im Innern Isolatoren sind. Zu dieser neuen...

Im Focus: Smarte Sensoren für effiziente Prozesse

Materialfehler im Endprodukt können in vielen Industriebereichen zu frühzeitigem Versagen führen und den sicheren Gebrauch der Erzeugnisse massiv beeinträchtigen. Eine Schlüsselrolle im Rahmen der Qualitätssicherung kommt daher intelligenten, zerstörungsfreien Sensorsystemen zu, die es erlauben, Bauteile schnell und kostengünstig zu prüfen, ohne das Material selbst zu beschädigen oder die Oberfläche zu verändern. Experten des Fraunhofer IZFP in Saarbrücken präsentieren vom 7. bis 10. November 2017 auf der Blechexpo in Stuttgart zwei Exponate, die eine schnelle, zuverlässige und automatisierte Materialcharakterisierung und Fehlerbestimmung ermöglichen (Halle 5, Stand 5306).

Bei Verwendung zeitaufwändiger zerstörender Prüfverfahren zieht die Qualitätsprüfung durch die Beschädigung oder Zerstörung der Produkte enorme Kosten nach...

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Alle Focus-News des Innovations-reports >>>



im innovations-report
in Kooperation mit academics

DFG unterstützt Kongresse und Tagungen - Dezember 2017

17.10.2017 | Veranstaltungen

Intelligente Messmethoden für die Bauwerkssicherheit: Fachtagung „Messen im Bauwesen“ am 14.11.2017

17.10.2017 | Veranstaltungen

Meeresbiologe Mark E. Hay zu Gast bei den "Noblen Gesprächen" am Beutenberg Campus in Jena

16.10.2017 | Veranstaltungen

Weitere VideoLinks >>>
Aktuelle Beiträge

Mikroben hinterlassen "Fingerabdrücke" auf Mars-Gestein

17.10.2017 | Biowissenschaften Chemie

Vorhersagen bestätigt: Schwere Elemente bei Neutronensternverschmelzungen nachgewiesen

17.10.2017 | Physik Astronomie

Kaiserschnitt-Risiko ist vererbbar

17.10.2017 | Biowissenschaften Chemie